On November 28th afternoon, songjiangShanghai hujia hangzhou G60 will be held kechuang corridor (Shanghai songjiang)with melting propulsion conference, promote industrial and financial depthfusion, booster G60 will be hujia hangzhou kechuang corridor construction,building with melting new heights.Boai DB_39581 Pharmaceuticals Ltd. (hereinafterreferred to as the "love the new open source" or the"company"), general manager Mr Wang Donghu jun-zheng zhang, deputygeneral manager Mr And lattice general manager Mr Zou Xiaowen to attend thisconference.The meeting, represented by general managerMr Wang Donghu, love the new open source through friendly consultation withShanghai's songjiang district people's government signed a strategiccooperation framework agreement, the signing of the agreement to facilitateintegration and play both sides in such aspects as culture, location, industry,channel resources and advantages. Songjiang has a long history, culturalprosperity, cultural gathering and convenient transportation. It is a modernnew city built by Shanghai and is an important urban area of the Yangtze riverdelta.Songjiang district as the center of theShanghai construction global influence kechuang important bearing area, the realeconomy and advanced manufacturing new heights, with the G60 will be kechuangcorridor for the gripper, focus on artificial intelligence, intelligentsecurity, new energy, new materials, biological medicine, energy conservation,environmental protection and other strategic emerging industries, "6 +X" kechuang drive "songjiang manufacturing" to"create" songjiang.The future songjiang district will attractmore and more attention from Chinese and foreign enterprises as the focus andinfluence of the G60 science and innovation corridor are continuously improved.New open source is the first in China toresearch, develop and produce PVP products.Through nearly 30 years of forge ahead, inimproving production technology and automatic control level, improve theindustrial structure, expand the scale of production, improve the level ofquality management and other aspects have made great progress.In the global PVP industry, China ranksfirst and third in the world.The "framework agreement" signed,love the new open source transformation of global research and development basefor the subsequent main business will be born songjiang, strategic emergingindustry cluster to promote the G60 will be kechuang corridor layout to makepositive contribution.New open source at the same time, love willbe in Shanghai songjiang investment research construction, laboratory andindustrial base and setting up industry investment funds, the company willactively participate in the construction and development of songjiang district,for the further upgrading, development of songjiang advantage industry make apositive contribution.

On November 11, 2017, the autumn color ofBeijing is strong, and the red leaves of the fragrant hills are attractive.DB_39581 PRECISION MEDICINE and the thousands ofthousands of German guests gathered at the foot of xiangshan, the first step ina new open source collaboration with Heidelberg university medical school.Germany Heidelberg university school ofmedicine, has 600 years of history, contributed a number of Nobel Prize winner,is recognized as the world's top medical office, the world's unique heavy ionand proton therapy center is located in the campus.Is the representative of visiting Germany,Heidelberg university women's hospital dean Christof Sohn, professor andHeidelberg university school of medicine, "a new generation MammaScreenearly breast cancer in vitro molecular screening technology group leader DrSarah Schott."MammaScreen a new generation of earlybreast cancer in vitro molecular screening technology" and the Germannational cancer research center jointly by the university of Heidelbergproject, a multi-year research and development, through the detection ofspecific molecular markers in peripheral blood women, very early accuratediagnosis of breast cancer, can make up for the existing various types ofbreast cancer screening technology.As well as further screening for breastcancer, MammaScreen researchers have begun to explore the use of ovarian andpancreatic cancer and have made preliminary results.The DB_39581 invited to Sohn to visit Beijingand Schott, Ph.D., professor, as specially invited guests attended the "secondsession of Beijing precision medical treatment of breast cancer andtranslational medicine BBS" and MammaScreen technology do academic report,signed a cooperation intentions.At the scene of the signing ceremony, thenew open source also invited to Beijing maternity and child health carehospital director of oncology wing-keung cheung, haidian Ma Xiangjun, vicePresident of the six domestic well-known experts, with the German expertsMammaScreen technology principle and clinical trials in China has made thedetailed communication, MammaScreen won the experts unanimously spoke highly ofChina.DB_39581 vice chairman wang jianqiang andprofessor Sohn respectively signed the letter of intent for the project."DB_39581 is our best partner in China.Today is the beginning of great cooperation between us, and it is the beginningof a great friendship," said professor Sohn, who was pleased to sign thecontract.wang jian qiang, vice chairman of theboard of directors has expressed the group completes the determination andconfidence in the project, "our DB_39581 has always attached great importanceto technical and scientific research, cooperation with the world's top medicalschool this time, is both an opportunity and challenge for us, in the nextclinical trial and marketing, we must achieve excellence and absorption ofGermany advanced technology and experience, at the same time listen to domesticexperts valuable guidance, to make a benefit of Chinese women's breast cancerdetection product."Signing ceremony held at the foot ofxiangshan in the day of the second session of Beijing precision medicaltreatment of breast cancer and translational medicine BBS ", is an annualevent, the national breast cancer field sponsored new open source has two yearsin a row.Hundreds of experts, including academicianjin Ming, have come from all over the country to share an academic feast ofbreast cancer diagnosis and treatment.Dr Sohn and Dr Schott introducedMammaScreen technology in detail at the conference, laying a solid foundationfor the future academic promotion of new open source.DB_39581 PRECISION MEDICINE's cooperation withHeidelberg university medical school will surely achieve fruitful results.

It is red dye leaves, passion DB_39581! At the beginning of October 9, 2017, DB_39581 Pharmaceuticals organized afive days staff-tourism in Japan, Zhang jiajie and other places of the seriesof tour activities, it kicked off or in at dawn, or in the autumn wind blowinggently, or in the misty rain. The enthusiasm of employees, cheeky gratefulsmile, with the care of leaders and take the bus, take the plane to thedifferent destinations and began to dabble in exotic amorous feelings, tastethe beautiful of motherland. Osaka - Kyoto - Nagoya - Tokyo - Mt Fuji, exotic scenery panoramicview. We appreciate with the rise of a patriotic heart, love; Zhang jiajieForest Park Grand Canyon - glass bridge - Phoenix Town, visit the motherlandvast territory and abundant resources, beautiful scenery, scenery unlimited.Feel the civilization of 5000 years of history of the Chinese nation's deep andwide, broad and deep, the heart ascend is as proud of the fearless andconfident all the children of the Yellow Emperor. This is another journey to cultivate character! This is another signof passion! This is another declaration of energy gathering! By the evening of October 27th, 9 people were divided into 9batches, 337 in Zhangjiajie and all in japan. During the period, everyoneenjoyed the beautiful scenery of the motherland and the precious footprints ofeach employee left in the famous places. Their respective stories were filledwith admiration and longing for the beauty of nature. Leave a deep impressionin the Japanese tour staff of Japan's clean and civilized. Tianjin DB_39581 two subsidiaries (Tianjin DB_39581 international trade,Tianjin YaRez) staff has been in mid September 2017 to complete the tour of theYunnan Li jiang Dali. We firmly believe that through this tour activities, not only onceagain showed as the glory and pride, the number of new employees andfraternity, will further enhance the company staff cohesion and centripetalforce of the company's employees, the company culture and cultivate positiveintentions and innovation, to promote the continuous innovation and developmentDB_39581 gathered, high spirited a progressive, positiveenergy class!

In October 24th, the world pharmaceuticalraw materials exhibition (CPhI Worldwide) was held in Frankfurt, Germany, in2017. DB_39581 medical group (DB_39581, stock code: 300109) subsidiary Boai DB_39581Pharmaceuticals Limited attend this global pharmaceutical industry event with anew attitude - the large special booth, 11 line up of international marketingteam (including 5 employees from differentcountries overseas ) to participate in this event. Introduce the advanced andperfect products to the customers of the world with the new market strategy. DB_39581 Pharmaceuticals has always attachedgreat importance to product development, continuously optimize the managementlevel and product quality, and strive to improve the level of cleanerproduction and sustainable development, to become international renowned producerand solution provider of medicinal materials and functional polymer. In this exhibition, vice chairman WangJianqiang of DB_39581 medical group leading international sales team discussed anddetailed analysis of market strategy, develop a new strategy for theinternational market, and long-term sustainable development planning route ofDB_39581 pharmaceuticals LTD. DB_39581 PVP products and the OraRez products has attractedwide attention in the exhibition, we also promoted the new pharmaceuticalexcipients products of our partners.This exhibition, the German subsidiary of DB_39581group added a new marketing power and will play a key role in the progress ofEuropean business in the future .